StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.96+0.07 (+3.70%)

Close on Nov 17, 2026Market cap $18.90MP/E –Yield –

Earnings

Edesa Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Dec 11, 2026
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.60
-$0.25 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Edesa Biotech's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Sep 30, 2026Dec 11, 2026Expected––––
Q3 FY2026ended Jun 30, 2026Aug 13, 2026after the close––-$0.60Release
Q2 FY2026ended Mar 31, 2026May 14, 2026after the close––-$0.49Release
Q1 FY2026ended Dec 31, 2025Feb 13, 2026after the close––-$0.28Release
Q4 FY2025ended Sep 30, 2025Dec 12, 2025after the close–––Release
Q3 FY2025ended Jun 30, 2025Aug 8, 2025after the close––-$0.25Release
Q2 FY2025ended Mar 31, 2025May 14, 2025after the close––-$0.30Release
Q1 FY2025ended Dec 31, 2024Feb 14, 2025after the close–––Release
Q4 FY2024ended Sep 30, 2024Dec 13, 2024after the close–––Release
Q3 FY2024ended Jun 30, 2024Aug 9, 2024after the close––-$0.52Release
Q2 FY2024ended Mar 31, 2024May 10, 2024after the close––-$0.58Release
Q1 FY2024ended Dec 31, 2023Feb 9, 2024after the close––-$0.54Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Edesa Biotech has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Edesa Biotech puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Edesa Biotech filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. News
  3. News
  4. Results
  5. Update
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. News
  12. Results
  13. News
  14. Results
  15. Results

See a number that looks wrong?